Nexium (Esomeprazole)

Esomeprazole (Nexium) is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions.

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH.
• Erosive oesophagitis: promotes healing of inflamed esophageal lining through acid suppression.
• NSAID‑induced gastric ulcer prevention: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (in combination therapy): enhances antibiotic effectiveness by creating a less acidic environment.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

• Esomeprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increase in gastric pH and allowing damaged mucosa to heal. The inhibition persists until new enzyme molecules are synthesized, providing prolonged acid control with once‑daily dosing.

Esomeprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild headache reported in clinical studies.
• Diarrhea: loose stools, usually self‑limiting.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk with prolonged use.
• Hypomagnesemia: low serum magnesium leading to muscle cramps or arrhythmia.
• Bone fracture: increased risk of hip, wrist or spine fractures with long‑term therapy.

When prescribing esomeprazole, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Monitor for infection: prolonged acid suppression can predispose to gastrointestinal infections.
• Evaluate bone health: long‑term therapy may affect calcium absorption.
• Check magnesium levels: periodic testing recommended during extended treatment.
• Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Esomeprazole can affect the plasma concentrations of other medicines through metabolic or absorption pathways.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect; avoid co‑administration.
• Atazanavir or other protease inhibitors: markedly decreased absorption; avoid.
• Methotrexate (high dose): increased toxicity risk; avoid.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation.
• Digoxin: reduced absorption; check serum levels.
• Diazepam: increased serum concentration; adjust dose if needed.